Data / Form D filings / Immorta Bio, Inc.
Immorta Bio, Inc.: Form D filing
Immorta Bio, Inc., a biotechnology company in Miami Beach, FL, filed a Form D with the SEC in 2026. The latest, on October 16, 2026, reports $612,503 sold of a $5 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7064 FISHER ISLAND DRIVE, Miami Beach, FL, 33109
- Phone
- (305) 632-2939
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2102665
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 16 | New notice | $5,000,000 | $612,503 | $4,387,497 | 6 | Nov 5 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Boris Reznik | Executive Officer |
Other biotechnology companies in Florida that filed recently
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13
- BioStem Technologies, Inc. $3 million · Oct 9
- HCW Biologics Inc. $1.5 million · Oct 8
- RHEOS MEDICAL CORP. $387,773 · Oct 7
Every Form D from the week of Oct 12 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Immorta Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.